A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ML / malignant lymphoma

[Related PubMed/MEDLINE]
Total Number of Papers: 283
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ML  (>> Co-occurring Abbreviation)
Long Form:   malignant lymphoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study. AMA, CR, LMIC, OS, PN
2019 The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies. FS-T2WI, GLCM, MR, ROI, SCC
2019 The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center. NHL
2019 Toxoplasma gondii infection in children with lymphoma in Eastern China: seroprevalence, risk factors and case-control studies. ---
2019 [A Case of Synchronous Diffuse Large B-Cell Lymphoma of the Right Breast and Invasive Ductal Carcinoma of the Left Breast]. BC
2019 [Clinical features of malignant orbital lymphoma]. ---
2018 Diagnostic accuracy and interobserver agreement of contrast-enhanced ultrasound in the evaluation of residual lesions after treatment for malignant lymphoma and testicular cancer: a retrospective pilot study in 52 patients. CEUS, HE, NE, RL, TC
2018 Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17. CCL17, DILD, KL-6, TARC
2018 Low level of serum HDL-cholesterol with increased sIL-2R predicts a poor clinical outcome for patients with malignant lymphoma and adult T-cell leukemia-lymphoma. ATLL, HDL-C, sIL-2R
10  2018 [Expression of sB7-H4 in Serum and Lymphoma Tissues of Patients with Malignant Lymphoma and Its Value for Diagnosis and Re-Examine of Lymphoma]. sB7-H4
11  2018 [Hemaorheology, Coagulation and Clinical Features of Malignant Lymphoma Combined with Venous Thromboembolism]. DVT, PE, VTE
12  2017 Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas. DLBCL, OS
13  2017 Clinical manifestation of malignant lymphomas of the head and neck region. HL, NHL
14  2017 Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET. AA, FDG, GBM, HB, LGG, MB, METs, Tl
15  2017 Malignant lymphoma in adolescents and young adults: from the viewpoint of physicians. AYA
16  2017 Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report. CT, MTX, PHL, RA
17  2017 The Usefulness of Positron-Emission Tomography Findings in the Management of Anterior Mediastinal Tumors. 18F-FDG, PET/CT, TC
18  2016 High prevalence of diffuse large B-cell lymphoma in occult hepatitis B virus-infected patients in the Tohoku district in Eastern Japan. HBV
19  2016 [Clinical Analysis of Adoptive Immunotherapy after Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in B Lymphocyte Malignant Lymphoma]. auto-PBHSCT, DFS, HL, NHL
20  2016 [Distribution of Pathogenic Bacteria and Its Influence on Expression of BCL-2 and BAX Protein after HSCT in the Patients with Hematological Malignancies]. CRP, HSCT
21  2015 A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation. auto-SCT, MM, SCT, VZV
22  2015 Clinical and histological aspects with therapeutic implications in head and neck lymphomas. ENT
23  2015 Clinical factors indicating the presence of malignant lymphoma before lymph node dissection. LDH, sIL-2R
24  2015 Diagnostic value of tumor blood flow and its histogram analysis obtained with pCASL to differentiate sinonasal malignant lymphoma from squamous cell carcinoma. CV, pCASL, ROC, ROI, SCC, TBF
25  2015 Predictors of the necessity for lymph node biopsy of cervical lymphadenopathy. CT, PL, RL, sIL-2R, TK, US
26  2015 Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria. DLBCL, HL, PFS
27  2015 The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors. ADC, DCE-MRI, MSGTs, Pleo, SCC, TK model, ve, vp
28  2014 Characteristic ultrasound features of mucosa-associated lymphoid tissue lymphoma of the salivary and thyroid gland. MALT
29  2014 EPSTEIN -BARR VIRUS ASSOCIATION WITH MALIGNANT LYMPHOMA SUBGROUPS IN ZARIA, NIGERIA. BL, CISH, EBV, HL
30  2014 FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/beta-catenin signaling pathway. GSK-3beta, MMP-2, MMP-9, NHL, VEGF
31  2014 Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children. KFD
32  2014 Malignant lymphoma in Eastern India: a retrospective analysis of 455 cases according to World Health Organisation classification. DLBCL, HL, IHC, NHL, WHO
33  2013 Axillary and intramammary lymphadenopathy caused by Kikuchi-Fujimoto disease mimicking malignant lymphoma. KFD
34  2013 Cervical lymph node extirpation for the diagnosis of malignant lymphoma. FNAC, LDH, sIL-2R
35  2013 Clinical significance of sIL-2R levels in B-cell lymphomas. DLBCL, FL, IHC, MMPs, sIL-2R, TAMs
36  2013 Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. G-CSF, PBSC, PCN, WBC
37  2013 Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions. BLN, DSUVmax
38  2013 Malignant lymphoma in Eastern India: A retrospective analysis of 455 cases according to World Health Organization classification. HL, NHL, WHO
39  2013 Mucosa-associated lymphoid tissue lymphoma of the thyroid with abundant IgG4-positive plasma cells. ATC, IgH, MALT
40  2013 [A case of primary malignant lymphoma of the prostate with characteristic MRI findings]. DLBCL, MRI, NHL, PSA
41  2013 [Clinical observation and long-time follow-up of patients with malignant lymphoma treated with autologous peripheral blood hematopoietic stem cell transplantation]. auto-PBHSCT, HD, NHL, TBI
42  2012 Low dose palliative radiotherapy for splenomegaly in hematologic disorders. CLL, MPD, MS, PSI, SM
43  2012 [Clinical observation of 100 patients with malignant lymphoma treating with different preconditioning regimens followed by autologous hematopoietic stem cell transplantation]. AHSCT, OS, PFS
44  2012 [Malignant lymphoma presenting as inflammation of unknown origin]. IVLBCL, sIL-2R
45  2011 Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. ALL, CI, HD-MTX, OR
46  2011 Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification. BL, DLBCL, FL, HL, MC, NHL, NS, WHO
47  2011 Preoperative diagnostic value of single-balloon enteroscopy for successful surgical treatment of three independent-origin gastrointestinal malignant tumors: report of a case. ---
48  2011 Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. ADL, CGA, IADL, pts
49  2011 [Extranodal NK/T-cell lymphoma, nasal type, developed in a patient with rheumatoid arthritis]. IS, MTX, RA
50  2010 A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation. auto-SCT, IFN-alpha, rIL-2, rIL-2
51  2010 A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. Ad6, COP, DNA-EP, dTERT, TERT
52  2010 Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. BMI, CIs, DLBCL, NHL, ORs
53  2010 Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). NHL, PCM
54  2010 Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience. DLBCL, ECR, FL
55  2010 Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? ALL, AML, BL, BM, ELISA, HL, NHL, sVEGF, VEGF
56  2010 Synchronous Gastric Carcinoma and Nodal Malignant Lymphoma: A Rare Case Report and Literature Review. GC
57  2010 Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association. ABC, Bcl, DI, DLBCL, FC, GCB, HL, IHC, ISH, MNH, NHL, WF
58  2010 The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. NHL, WHO
59  2010 [Malignant lymphoma associated with primary Sjogren's syndrome]. pSS
60  2009 Biopsy of cervical lymph node. CRP, LDH, sIL-2R, WBC
61  2009 Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification. DLBCL, FL, HL, KFSH, KSA, NHL, NSCHL, PFOC, SLL
62  2009 Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay. AZTMP, LEUK, REA
63  2009 Superior clinical impact of FDG-PET compared to MRI for the follow-up of a patient with sacral lymphoma. MRI
64  2009 Zinc and selenium status in pediatric malignant lymphomas. Se, Zn
65  2009 [Mediastinal large B-cell lymphoma associated with systemic sclerosis]. SSc
66  2008 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. CT, MRI, PET
67  2008 Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution. ALL, AML, MDS, MPD, PCPD
68  2008 Differential diagnostic features of small cell carcinoma in the uterine cervix. CLC, SCIS, SmCC
69  2008 Epidural malignant lymphomas of the spine: collected experiences with epidural malignant lymphomas of the spinal canal and their treatment. CT, MR
70  2008 Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis. HL, NHL
71  2008 Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells. G-CSF, HD, IL-2, MNC, NKT, PB
72  2008 Malignant lymphomas (ML) and HIV infection in Tanzania. ARL, HD, MNH, MUHAS, PCNSL, PEL
73  2008 Multiple anechoic hepatic nodules in a patient with malignant lymphoma: report of a case with an emphasis on B-mode sonograms. US
74  2008 The effect of accessibility to drugs on outcome of therapy in patients with malignant lymphoma. NHL, RR
75  2007 Clinical, histopathological and immunophenotypical findings in five horses with cutaneous malignant lymphoma. FNA, IHC
76  2007 Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not. BD, CTGF, MM, MMP
77  2007 Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic? MDS, NHL, RP
78  2007 Synchronous squamous cell carcinoma and malignant lymphoma in the head and neck region. SCC
79  2007 [The clinical value of the 99Tcm-MIBI imaging in predicting the prognosis of malignant lymphoma]. RT-PCR, T/B
80  2006 A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs. CC, ELISA, LDH, SEE, STK1, TK, U/L, WHO
81  2006 AIDS and non AIDS-related malignant lymphoma in Tanzania. ARL, EBER, EBV, KS, PCR
82  2006 Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: cytologic features of fine-needle aspiration smears with Pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation. FL, FNAC, RFH
83  2005 18F-FDG PET in malignant lymphoma: significance of positive findings. FDG, HD, NHL, PET
84  2005 A Case of Burkitt's Lymphoma Involving Both Breasts. CHOP, FNAC
85  2005 A case of vogt-koyanagi-harada disease associated with malignant lymphoma. sIL-2R, VKH
86  2005 Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification. CL, HF, NKTLs, WHO
87  2005 Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjogren's syndrome. HSG, SLE, SS
88  2005 Successful endoscopic hemostasis for gastric arterial bleeding due to invasion of malignant lymphoma. ---
89  2005 The co-existence of pure red cell aplasia and autoimmune haemolytic anaemia in a child with malignant lymphoma. AIHA, PRCA
90  2005 The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy. AML, CML, MDS, PB
91  2005 [Malignant lymphoma of the ureter: a case report]. TCC
92  2004 Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. AML, CR, MS
93  2004 Male sexuality after cancer treatment--needs for information and support: testicular cancer compared to malignant lymphoma. TC
94  2004 Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease. CR, S-TK
95  2004 [A paired case-control study for assessing the relationship between the incidence of malignant lymphomas and the viruses infections]. CMV, EBER-ISH, EBV, ELISA, HBV, HCV, HIV
96  2003 High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma. allo-HSCT, RI
97  2003 Primary central nervous system (CNS) malignant lymphoma (ML), diffuse large cell type. CNS
98  2003 Surgical resection of malignant lymphoma in the right atrium after systemic chemotherapy. RA, TEE
99  2003 [A case-control study for assessing the relation between the incidence of malignant lymphomas and environmental factors in Sichuan province]. AOR
100  2003 [Lymphoma prognostic correlated factors analysis of 88 cases]. HL, NHL